Cargando…

Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study

To validate the correlation between ANXA3 expression and prognosis in breast cancer, a retrospective study encompassing 309 breast cancer patients was performed. The expression of ANXA3 was determined by the immunohistochemical examination of tissue sections by the Max Vision™ method. The ANXA3 leve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Tao, Li, Yong, Yang, Li, Tang, Tiantian, Zhang, Lina, Shi, Jiajie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406736/ https://www.ncbi.nlm.nih.gov/pubmed/28497041 http://dx.doi.org/10.1155/2017/2603685

Ejemplares similares

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
por: Gou, Rui, et al.
Publicado: (2019)

Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer
por: Choi, Chel Hun, et al.
Publicado: (2016)

Annexin A3 and cancer
por: Liu, Chao, et al.
Publicado: (2021)

Role of annexin A3 in breast cancer (Review)
por: Ozturk, Alpaslan
Publicado: (2022)

Annexin A2 and FTH1 are potential biomarkers for lupus nephritis
por: Zhou, Yanni, et al.
Publicado: (2018)

Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomas
por: Li, Shuang, et al.
Publicado: (2017)

Analysis of the Expression and Prognostic Value of Annexin Family Proteins in Bladder Cancer
por: Wu, WenBo, et al.
Publicado: (2021)

Expression levels and prognostic values of annexins in liver cancer
por: Zhuang, Chunbo, et al.
Publicado: (2019)

Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis
por: Yang, Xiaolu, et al.
Publicado: (2023)

Upregulated expression of Annexin II is a prognostic marker for patients with gastric cancer
por: Zhang, Qi, et al.
Publicado: (2012)

Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer
por: Du, Ruikai, et al.
Publicado: (2018)

Overexpression of Annexin A2 Is Associated with Abnormal Ubiquitination in Breast Cancer
por: Deng, Shishan, et al.
Publicado: (2012)

Prognostic value of Annexin A3 in human colorectal cancer and its correlation with hypoxia-inducible factor-1α
por: XIE, YONG-QIU, et al.
Publicado: (2013)

Clinical Significance of Annexin A1 Expression in Breast Cancer
por: Yom, Cha Kyong, et al.
Publicado: (2011)

Annexin A protein family: Focusing on the occurrence, progression and treatment of cancer
por: Zhang, Huhu, et al.
Publicado: (2023)

Gastric and adrenal metastasis from breast cancer: Case report and review of literature
por: Tang, Tiantian, et al.
Publicado: (2020)

Annexin A3, a Calcium-Dependent Phospholipid-Binding Protein: Implication in Cancer
por: Yang, Liu, et al.
Publicado: (2021)

SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer
por: Zhu, Youzhi, et al.
Publicado: (2023)

Annexins in Glaucoma
por: Yap, Timothy E., et al.
Publicado: (2018)

Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
por: LIU, ZHIKUN, et al.
Publicado: (2013)

Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
por: Shaker, Mohamed K, et al.
Publicado: (2017)

Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis
por: Herrera-López, Ema Elvira, et al.
Publicado: (2023)

The annexins
por: Moss, Stephen E, et al.
Publicado: (2004)

Annexin A1 attenuates EMT and metastatic potential in breast cancer
por: Maschler, Sabine, et al.
Publicado: (2010)

Clinical Significance of Annexin A2 Expression in Breast Cancer Patients
por: Gibbs, Lee D., et al.
Publicado: (2020)

Identification of natural compounds targeting Annexin A2 with an anti-cancer effect
por: Wang, Yu-Shi, et al.
Publicado: (2018)

Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma
por: Kotepui, Kwuntida U, et al.
Publicado: (2022)

(20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2
por: Wang, Yu-Shi, et al.
Publicado: (2021)

Annexin A3 Is a Potential Predictor of Platinum Resistance in Epithelial Ovarian Cancer Patients in a Prospective Cohort
por: Jin, Ying, et al.
Publicado: (2015)

Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer
por: Queiroz, Cleberson Jean dos Santos, et al.
Publicado: (2014)

Phosphatidylserine-Exposing Annexin A1-Positive Extracellular Vesicles: Potential Cancer Biomarkers
por: Perez, Gloria I., et al.
Publicado: (2023)

Identification of ZG16B as a prognostic biomarker in breast cancer
por: Lu, Haotian, et al.
Publicado: (2020)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

Annexin A1 is a potential biomarker of bone metastasis in small cell lung cancer
por: Chen, Peng, et al.
Publicado: (2021)

Prognostic role of serum soluble ST2 of advanced breast cancer patients: a retrospective cohort study
por: Chen, Chong, et al.
Publicado: (2023)

Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target
por: Zeidan, Bashar, et al.
Publicado: (2015)

Annexin A3 Knockdown Suppresses Lung Adenocarcinoma
por: Liu, Ying-Fu, et al.
Publicado: (2016)

Annexins in Influenza Virus Replication and Pathogenesis
por: Ampomah, Patrick Baah, et al.
Publicado: (2018)

Prognosis and clinicopathological characteristics of metaplastic breast cancer: A meta-analysis
por: Yang, Xiaolu, et al.
Publicado: (2022)

Special Issue “Recent Developments in Annexin Biology”
por: Rescher, Ursula, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qigdcfld8tbvhv1qppueodh3i3